Related references
Note: Only part of the references are listed.Small molecules regulating reactive oxygen species homeostasis for cancer therapy
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Natural Molecules Targeting Thioredoxin System and Their Therapeutic Potential
Junmin Zhang et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site
Shuo Chen et al.
CANCER CELL (2021)
Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment
Ying Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Thioredoxin reductase is a major regulator of metabolism in leukemia cells
Sheelarani Karunanithi et al.
ONCOGENE (2021)
The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia
Dongdong Zhang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Decrease of Protein Vicinal Dithiols in Parkinsonism Disclosed by a Monoarsenical Fluorescent Probe
Guodong Hu et al.
ANALYTICAL CHEMISTRY (2020)
The Thioredoxin System: A Promising Target for Cancer Drug Development
Hiba Ghareeb et al.
CHEMISTRY-A EUROPEAN JOURNAL (2020)
Dual Inhibition of Pyruvate Dehydrogenase Complex and Respiratory Chain Complex Induces Apoptosis by a Mitochondria-Targeted Fluorescent Organic Arsenical in vitro and in vivo
Yu-Jiao Liu et al.
CHEMMEDCHEM (2020)
Sanguinarine as a new chemical entity of thioredoxin reductase inhibitor to elicit oxidative stress and promote tumor cell apoptosis
Juan Yao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Potent Inhibition of Thioredoxin Reductase by the Rh Derivatives of Anticancer M(arene/Cp*)(NHC)Cl2 Complexes
Dianna Truong et al.
INORGANIC CHEMISTRY (2020)
Irreversible TrxR1 inhibitors block STAT3 activity and induce cancer cell death
S. Busker et al.
SCIENCE ADVANCES (2020)
Halo and Pseudohalo Gold(I)-NHC Complexes Derived from 4,5-Diarylimidazoles with Excellent In Vitro and In Vivo Anticancer Activities Against HCC
Mianli Bian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design and SAR of Withangulatin A Analogues that Act as Covalent TrxR Inhibitors through the Michael Addition Reaction Showing Potential in Cancer Treatment
Cheng Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor
Qing-Zhu Fan et al.
BIOORGANIC CHEMISTRY (2020)
Small molecule inhibitors of mammalian thioredoxin reductase as potential anticancer agents: An update
Junmin Zhang et al.
MEDICINAL RESEARCH REVIEWS (2019)
Evolution of the thioredoxin system as a step enabling adaptation to oxidative stress
Monica Balsera et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Promotion of HeLa cells apoptosis by cynaropicrin involving inhibition of thioredoxin reductase and induction of oxidative stress
Tianyu Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Targeting the Thioredoxin System as a Strategy for Cancer Therapy
Mianli Bian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent
Denana Miodragovic et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Small molecule fluorescent probes of protein vicinal dithiols
Guodong Hu et al.
CHINESE CHEMICAL LETTERS (2019)
A fast and specific fluorescent probe for thioredoxin reductase that works via disulphide bond cleavage
Xinming Li et al.
NATURE COMMUNICATIONS (2019)
A mitochondria-targeted organic arsenical accelerates mitochondrial metabolic disorder and function injury
Xiao-Yang Fan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
LDHA Suppression Altering Metabolism Inhibits Tumor Progress by an Organic Arsenical
Yu-Jiao Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A gold(I) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs
Claudia Schmidt et al.
METALLOMICS (2019)
Direct Polymerization of the Arsenic Drug PENAO to Obtain Nanoparticles with High Thiol-Reactivity and Anti-Cancer Efficiency
Janina-Miriam Noy et al.
BIOCONJUGATE CHEMISTRY (2018)
Organic arsenicals target thioredoxin reductase followed by oxidative stress and mitochondrial dysfunction resulting in apoptosis
Xiao-Yang Fan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
The A to Z of modulated cell patterning by mammalian thioredoxin reductases
Markus Dagnell et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors
Valeria Scalcon et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy
William C. Stafford et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Small Molecules to Target the Selenoprotein Thioredoxin Reductase
Baoxin Zhang et al.
CHEMISTRY-AN ASIAN JOURNAL (2018)
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
Shingo Kozono et al.
NATURE COMMUNICATIONS (2018)
Thioredoxin reductase inhibitors: a patent review
Baoxin Zhang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Targeting the Thioredoxin System for Cancer Therapy
Junmin Zhang et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
p-Azidophenylarsenoxide: An Arsenical Bait for the In Situ Capture and Identification of Cellular Arsenic-Binding Proteins
Xiaowen Yan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Oxidative stress-mediated intrinsic apoptosis in human promyelocytic leukemia HL-60 cells induced by organic arsenicals
Xiao-Yang Fan et al.
SCIENTIFIC REPORTS (2016)
Synthesis of Xanthohumol Analogues and Discovery of Potent Thioredoxin Reductase Inhibitor as Potential Anticancer Agent
Baoxin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Organic Arsenicals As Efficient and Highly Specific Linkers for Protein/Peptide-Polymer Conjugation
Paul Wilson et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2015)
Acute promyelocytic leukemia: where did we start, where are we now, and the future
C. C. Coombs et al.
BLOOD CANCER JOURNAL (2015)
Shikonin targets cytosolic thioredoxin reductase to induce ROS-mediated apoptosis in human promyelocytic leukemia HL-60 cells
Dongzhu Duan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Dithiaarsanes Induce Oxidative Stress-Mediated Apoptosis in HL-60 Cells by Selectively Targeting Thioredoxin Reductase
Yaping Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Highly Selective Off-On Fluorescent Probe for Imaging Thioredoxin Reductase in Living Cells
Liangwei Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Robust Structure and Reactivity of Aqueous Arsenous Acid-Platinum(II) Anticancer Complexes
Denana U. Miodragovic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Arsenic Binding to Proteins
Shengwen Shen et al.
CHEMICAL REVIEWS (2013)
The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase
Danielle Park et al.
CANCER CELL INTERNATIONAL (2012)
Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations
Balaraman Kalyanaraman et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Arsenic: toxicity, oxidative stress and human disease
K. Jomova et al.
JOURNAL OF APPLIED TOXICOLOGY (2011)
Crystal structure of the human thioredoxin reductase-thioredoxin complex
Karin Fritz-Wolf et al.
NATURE COMMUNICATIONS (2011)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
Arsenic Trioxide Controls the Fate of the PML-RARα Oncoprotein by Directly Binding PML
Xiao-Wei Zhang et al.
SCIENCE (2010)
Coencapsulation of Arsenic- and Platinum-based Drugs for Targeted Cancer Treatment
Haimei Chen et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide
Jun Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Para to Ortho repositioning of the arsenical moiety of the angiogenesis inhibitor 4-(N-(S-glutathionylacetyl)amino) phenylarsenoxide results in a markedly increased cellular accumulation and antiproliferative activity
PJ Dilda et al.
CANCER RESEARCH (2005)
JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells
K Davison et al.
BLOOD (2004)
The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future
AM Evens et al.
LEUKEMIA RESEARCH (2004)
In vitro effect of arsenical compounds on glutathione-related enzymes
S Chouchane et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Structure and mechanism of mammalian thioredoxin reductase:: The active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence
LW Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
